NCT02452684已完成不适用
Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients (Study LUN01S)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 4,876
- 主要终点
- Assessment of overall improvement
研究概览
简要总结
To investigate the safety and efficacy of administration of eszopiclone for 4 weeks in insomnia patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Insomnia participants who did not take eszopiclone before assessment
- •Participants who receive assessment by using sleep questionaries
排除标准
- 未提供
研究组 & 干预措施
Participants with insomnia
Participants with insomnia who will receive eszopiclone, per approved label.
干预措施: Eszopiclone (Drug)
结局指标
主要结局
Assessment of overall improvement
时间窗: Up to 4 weeks
Participants will be interviewed regarding sleep improvement at 4 weeks after first dose or discontinuation relative to predose, and select the appropriate answer of: 1. Improved 2. Unchanged 3. Worse 4. Indiscernible
次要结局
- Number of participants with adverse events (AEs)(Up to 4 weeks)
研究者
相似试验
已完成
不适用
Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia PatientsInsomniaNCT02455271Eisai Co., Ltd.438
已完成
4 期
Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress DisorderPost-Traumatic Stress DisordersNCT00120250Massachusetts General Hospital27
已完成
4 期
Eszopiclone in the Treatment of Insomnia and FibromyalgiaInsomniaFibromyalgiaNCT00392041Lesley A. Allen, Ph.D.36
已完成
不适用
Sleep Loss and Mechanisms of Impaired Glucose MetabolismPrimary InsomniaNCT00555750Brigham and Women's Hospital20
已完成
不适用
Insomnia and Osteoarthritis StudyOsteoarthritisInsomniaNCT00374556Johns Hopkins University30